Neuberger Berman Group LLC Has $11.64 Million Holdings in Cardiovascular Systems, Inc. (NASDAQ:CSII)

Posted by Defense World Staff on Jun 9th, 2023

Neuberger Berman Group LLC cut its position in Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) by 0.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 854,923 shares of the medical device company’s stock after selling 4,619 shares during the quarter. Neuberger Berman Group LLC owned approximately 2.04% of Cardiovascular Systems worth $11,640,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Point72 Hong Kong Ltd bought a new stake in shares of Cardiovascular Systems during the 2nd quarter valued at $34,000. HighMark Wealth Management LLC bought a new position in shares of Cardiovascular Systems in the 4th quarter valued at $35,000. Quadrant Capital Group LLC lifted its stake in shares of Cardiovascular Systems by 179.2% in the fourth quarter. Quadrant Capital Group LLC now owns 2,993 shares of the medical device company’s stock worth $41,000 after acquiring an additional 1,921 shares during the period. Performa Ltd US LLC lifted its position in shares of Cardiovascular Systems by 60.5% during the 4th quarter. Performa Ltd US LLC now owns 3,450 shares of the medical device company’s stock valued at $47,000 after acquiring an additional 1,300 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Cardiovascular Systems by 105.2% in the third quarter. Tower Research Capital LLC TRC now owns 4,670 shares of the medical device company’s stock valued at $64,000 after purchasing an additional 2,394 shares during the last quarter. 86.61% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CSII has been the topic of several analyst reports. Lake Street Capital downgraded Cardiovascular Systems from a “buy” rating to a “sell” rating in a report on Thursday, February 9th. StockNews.com began coverage on Cardiovascular Systems in a report on Tuesday. They set a “hold” rating for the company.

Cardiovascular Systems Stock Performance

CSII opened at $20.00 on Friday. Cardiovascular Systems, Inc. has a twelve month low of $12.26 and a twelve month high of $20.57. The firm has a market capitalization of $843.96 million, a PE ratio of -20.62 and a beta of 0.74. The firm’s 50-day moving average price is $19.97 and its 200 day moving average price is $17.43. The company has a current ratio of 6.04, a quick ratio of 4.92 and a debt-to-equity ratio of 0.08.

About Cardiovascular Systems

(Get Rating)

Cardiovascular Systems, Inc is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St.